JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GSV
3026
DELISTED
Gold Standard Ventures Corp.
GSV
| $2.73M | ﹤0.01% |
2,572,730
-119,782
| -4% | -$125K |
2018 Q1
5 quarters
|
|
3027
CALL
Genuine Parts
GPC
$17.6B
| $2.73M | ﹤0.01% |
26,500
+3,000
| +13% | +$311K |
2019 Q1
1 quarter
|
|
3028
PUT
Pinterest
PINS
$11.3B
| $2.72M | ﹤0.01% |
+100,000
| New | +$2.73M |
2019 Q2
0 quarters
|
|
3029
Resideo Technologies
REZI
$2.87B
| $2.71M | ﹤0.01% |
128,464
-28,924
| -18% | -$611K |
2018 Q4
2 quarters
|
|
|
JCAP
3030
DELISTED
Jernigan Capital, Inc.
JCAP
| $2.71M | ﹤0.01% |
129,196
-3,566
| -3% | -$75.1K |
2016 Q4
10 quarters
|
|
3031
Arlo Technologies
ARLO
$1.38B
| $2.7M | ﹤0.01% |
682,801
-55,074
| -7% | -$216K |
2018 Q3
3 quarters
|
|
3032
Santander
BSBR
$44.8B
| $2.7M | ﹤0.01% |
237,992
-97,590
| -29% | -$1.06M |
2015 Q3
15 quarters
|
|
3033
CALL
Zscaler
ZS
$34.6B
| $2.7M | ﹤0.01% |
+34,800
| New | +$2.48M |
2019 Q2
0 quarters
|
|
3034
CALL
DXC Technology
DXC
$1.89B
| $2.69M | ﹤0.01% |
+50,000
| New | +$2.89M |
2019 Q2
0 quarters
|
|
|
UHT
3035
Universal Health Realty Income Trust
UHT
$520M
| $2.69M | ﹤0.01% |
32,032
+12,689
| +66% | +$1.04M |
2013 Q2
24 quarters
|
|
|
GOGL
3036
DELISTED
Golden Ocean Group
GOGL
| $2.69M | ﹤0.01% |
472,140
+246,060
| +109% | +$1.29M |
2018 Q2
4 quarters
|
|
3037
Independence Realty Trust
IRT
$3.47B
| $2.68M | ﹤0.01% |
233,328
+46,174
| +25% | +$507K |
2016 Q1
13 quarters
|
|
3038
Markel Group
MKL
$21.5B
| $2.68M | ﹤0.01% |
2,501
+1,000
| +67% | +$1.05M |
2013 Q2
24 quarters
|
|
3039
Greenlight Captial
GLRE
$478M
| $2.67M | ﹤0.01% |
316,146
-94,445
| -23% | -$972K |
2017 Q4
6 quarters
|
|
|
ITCI
3040
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.67M | ﹤0.01% |
210,531
-7,045
| -3% | -$90.4K |
2017 Q3
7 quarters
|
|
3041
Cactus
WHD
$4.47B
| $2.67M | ﹤0.01% |
84,036
+31,556
| +60% | +$1.1M |
2018 Q1
5 quarters
|
|
3042
Adtran
ADTN
$621M
| $2.67M | ﹤0.01% |
176,861
-193,128
| -52% | -$3.08M |
2015 Q3
15 quarters
|
|
3043
Usana Health Sciences
USNA
$274M
| $2.67M | ﹤0.01% |
34,781
-77,123
| -69% | -$6.12M |
2013 Q2
24 quarters
|
|
3044
CALL
ASML
ASML
$704B
| $2.67M | ﹤0.01% |
13,000
| – | – |
2019 Q1
1 quarter
|
|
|
3045
PUT
ASML
ASML
$704B
| $2.67M | ﹤0.01% |
13,000
| – | – |
2019 Q1
1 quarter
|
|
3046
Eldorado Gold
EGO
$10.1B
| $2.66M | ﹤0.01% |
463,045
+461,520
| +30,264% | +$1.95M |
2013 Q2
24 quarters
|
|
3047
Ligand Pharmaceuticals
LGND
$5.92B
| $2.66M | ﹤0.01% |
37,403
-1,572
| -4% | -$116K |
2015 Q4
14 quarters
|
|
3048
SITE Centers
SITC
$168M
| $2.66M | ﹤0.01% |
259,680
+48,209
| +23% | +$505K |
2013 Q2
24 quarters
|
|
3049
Cooper-Standard Automotive
CPS
$394M
| $2.65M | ﹤0.01% |
59,069
+6,610
| +13% | +$315K |
2016 Q1
13 quarters
|
|
3050
Sensata Technologies
ST
$6.39B
| $2.65M | ﹤0.01% |
54,391
-6,858
| -11% | -$326K |
2013 Q2
24 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.